ATE497767T1 - Verfahren zur behandlung von entzündungserkrankungen - Google Patents
Verfahren zur behandlung von entzündungserkrankungenInfo
- Publication number
- ATE497767T1 ATE497767T1 AT07864191T AT07864191T ATE497767T1 AT E497767 T1 ATE497767 T1 AT E497767T1 AT 07864191 T AT07864191 T AT 07864191T AT 07864191 T AT07864191 T AT 07864191T AT E497767 T1 ATE497767 T1 AT E497767T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutically acceptable
- inflammatory diseases
- acceptable salts
- treating inflammatory
- compounds
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- BBACKDMGYMXYLE-UHFFFAOYSA-N 3-thiophen-2-ylpiperazin-2-one Chemical compound O=C1NCCNC1C1=CC=CS1 BBACKDMGYMXYLE-UHFFFAOYSA-N 0.000 abstract 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 abstract 1
- 208000010247 contact dermatitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229950004600 tenilsetam Drugs 0.000 abstract 1
- 230000005951 type IV hypersensitivity Effects 0.000 abstract 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Surgical Instruments (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86531506P | 2006-11-10 | 2006-11-10 | |
| PCT/US2007/084214 WO2008060982A1 (en) | 2006-11-10 | 2007-11-09 | Methods for treating inflammatory conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE497767T1 true ATE497767T1 (de) | 2011-02-15 |
Family
ID=39401998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07864191T ATE497767T1 (de) | 2006-11-10 | 2007-11-09 | Verfahren zur behandlung von entzündungserkrankungen |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US8716294B2 (de) |
| EP (1) | EP2083824B1 (de) |
| AT (1) | ATE497767T1 (de) |
| DE (1) | DE602007012458D1 (de) |
| WO (1) | WO2008060982A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6608094B2 (en) * | 1999-10-06 | 2003-08-19 | Torrent Pharmaceuticals Ltd. | Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| US20060286046A1 (en) * | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
| EP2932958A1 (de) * | 2007-02-22 | 2015-10-21 | Beiersdorf AG | Kosmetische und pharmazeutische Anwendungen von N-acetylhydroxyprolin |
-
2007
- 2007-11-09 WO PCT/US2007/084214 patent/WO2008060982A1/en active Application Filing
- 2007-11-09 EP EP07864191A patent/EP2083824B1/de not_active Not-in-force
- 2007-11-09 DE DE602007012458T patent/DE602007012458D1/de active Active
- 2007-11-09 US US11/937,680 patent/US8716294B2/en not_active Expired - Fee Related
- 2007-11-09 AT AT07864191T patent/ATE497767T1/de not_active IP Right Cessation
-
2014
- 2014-04-17 US US14/254,947 patent/US9408844B2/en not_active Expired - Fee Related
-
2016
- 2016-08-08 US US15/231,059 patent/US20170173004A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2083824A1 (de) | 2009-08-05 |
| DE602007012458D1 (de) | 2011-03-24 |
| WO2008060982A1 (en) | 2008-05-22 |
| EP2083824B1 (de) | 2011-02-09 |
| US20170173004A1 (en) | 2017-06-22 |
| US8716294B2 (en) | 2014-05-06 |
| EP2083824A4 (de) | 2009-11-25 |
| US9408844B2 (en) | 2016-08-09 |
| US20140227209A1 (en) | 2014-08-14 |
| US20080161319A1 (en) | 2008-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE495743T1 (de) | Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten | |
| DE602007006010D1 (de) | Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten | |
| RU2018145985A (ru) | Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений | |
| ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
| MY163275A (en) | Ibat inhibitors for the treatment of liver diseases | |
| CR11580A (es) | Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf | |
| MX2008012479A (es) | Tratamiento de enfermedades neurodegenerativas. | |
| EA200970483A1 (ru) | Применение пролекарств габапентина и прегабалина для лечения шума в ушах | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| AR050717A1 (es) | Composiciones farmaceuticas | |
| RS53598B1 (en) | TOPICAL PREPARATIONS FOR THE CONSERVATION OR RE-ESTABLISHMENT OF MALFIN INTEGRITY | |
| EA201001639A1 (ru) | Композиции и способы их получения и применения | |
| WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
| DE602006019468D1 (de) | Diarylharnstoffe zur behandlung von pulmonaler hypertonie | |
| MX2011012015A (es) | Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer. | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| ATE533488T1 (de) | Verfahren und formulierungen zur modulierung von lyn-kinaseaktivität und behandlung assoziierter erkrankungen | |
| CY1115081T1 (el) | Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του | |
| WO2010044585A3 (en) | Piperidine compounds, pharmaceutical composition comprising the same and its use | |
| EA200970164A1 (ru) | Ингибиторы каспазы на основе пиридазинонового каркаса | |
| RS54185B1 (en) | USE OF 24-ORDER | |
| IT1397446B1 (it) | Compositions comprising amino acids for prevention and/or treatment of renal disorders. | |
| WO2009155070A3 (en) | Compositions and methods for treatment of inflammation and hyperkeratotic lesions | |
| WO2008036733A3 (en) | Methods for treatment of vesicle transport disorders | |
| ATE497767T1 (de) | Verfahren zur behandlung von entzündungserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |